Wildfires are becoming more frequent and more intense worldwide. Fires often become infernos because of heat, drought and wind, especially in the summer. The problem is compounded by the climate ...
Are you passionate about developing AI-based and quantum-inspired solutions for the next generation of sustainable energy systems? We are now looking for a fully funded Doctoral Researcher to work on ...
Two researchers at the Institute for Neurosciences (IN), a joint center of the Spanish National Research Council (CSIC) and the Miguel Hernández University of Elche (UMH), have developed a new ...
New research from UBC Okanagan mathematically demonstrates that the universe cannot be simulated. Using Gödel’s incompleteness theorem, scientists found that reality requires “non-algorithmic ...
Scientists in Germany have pulled off a staggering computing feat by fully simulating a 50-qubit quantum computer for the first time ever using Europe’s new exascale supercomputer, JUPITER. The ...
GPT-Realtime-2 brings GPT-5-class reasoning to live voice. A separate translation model covers 70+ input languages. A streaming Whisper variant handles transcription. The pricing is aggressive enough ...
OpenAI’s latest voice AI model, GPT Realtime 2, introduces advanced capabilities for natural and context-aware interactions. Built on the GPT-5-level reasoning framework, it handles complex tasks such ...
OpenAI said Thursday that its API will now include a number of new voice intelligence features designed to help developers create apps that can talk, transcribe, and translate conversations with users ...
May 7 (Reuters) - OpenAI introduced three audio models for its developer platform on Thursday, aiming to make voice-based software agents more ‌conversational and capable of completing tasks in real ...
WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the ‌agency to monitor clinical trial data in real time, a step the agency ...
On a press call, FDA Commissioner Marty Makary, M.D., highlighted the potential for FDA staff to keep up with trials as they are happening and potentially make regulatory decisions without having to ...